SCM
Sio Capital Management Portfolio holdings
AUM
$395M
1-Year Est. Return
196.27%
1 Year Est. Return
+196.27%
AUM
$249M
AUM Growth
-$81M
(-25%)
Holding
64
Top Buys
| 1 | +$14.2M | |
| 2 | +$11.2M | |
| 3 | +$9.06M | |
| 4 |
Edgewise Therapeutics
EWTX
|
+$7.08M |
| 5 |
Maximus
MMS
|
+$5.6M |
Top Sells
| 1 | +$35.6M | |
| 2 | +$21.2M | |
| 3 | +$19.5M | |
| 4 |
Teleflex
TFX
|
+$14.9M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$10.9M |
Sector Composition
| 1 | Healthcare | 83.62% |
| 2 | Industrials | 15.44% |
| 3 | Technology | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Maximus
MMS
$4.5B
| $38.5M | 14.69% |
548,086
+79,734
|
|
||
2
Disc Medicine
IRON
$3.4B
| $15.1M | 5.76% |
284,787
+211,276
|
|
||
3
Globus Medical
GMED
$11.3B
| $14.5M | 5.54% |
245,570
+38,570
|
|
||
4
Centene
CNC
$17.9B
| $14.2M | 5.44% |
+262,500
|
|
||
5
Merck
MRK
$231B
| $13.8M | 5.26% |
173,951
-96,645
|
|
||
|
DRUG
6
Bright Minds Biosciences
DRUG
$410M
| $13.4M | 5.11% |
512,338
+4,776
|
|
||
|
7
Neurocrine Biosciences
NBIX
$14.4B
| $12.7M | 4.84% |
100,725
-86,848
|
|
||
8
BioMarin Pharmaceuticals
BMRN
$10.5B
| $12.4M | 4.73% |
225,114
+83,980
|
|
||
9
Annexon
ANNX
$324M
| $9.83M | 3.75% |
4,095,764
+697,978
|
|
||
10
Sanofi
SNY
$127B
| $9.06M | 3.46% |
+187,500
|
|
||
11
Tyra Biosciences
TYRA
$840M
| $7.75M | 2.96% |
810,274
+393,657
|
|
||
12
ANI Pharmaceuticals
ANIP
$1.89B
| $7.37M | 2.81% |
112,923
+25,625
|
|
||
|
13
Edgewise Therapeutics
EWTX
$2.41B
| $7.08M | 2.7% |
+539,730
|
|
||
|
AVR
14
Anteris Technologies
AVR
$152M
| $6.97M | 2.66% |
1,839,022
-530,938
|
|
||
|
SEPN
15
Septerna Inc
SEPN
$1.04B
| $6.18M | 2.36% |
584,435
-204,235
|
|
||
16
Artivion
AORT
$2.17B
| $4.94M | 1.89% |
158,736
+37,558
|
|
||
17
Dianthus Therapeutics
DNTH
$1.75B
| $4.4M | 1.68% |
236,070
+119,073
|
|
||
18
ProQR Therapeutics
PRQR
$229M
| $4.23M | 1.62% |
2,075,139
+20,546
|
|
||
19
PMV Pharmaceuticals
PMVP
$73.4M
| $3.96M | 1.51% |
3,735,396
|
|
||
20
Avanos Medical
AVNS
$529M
| $3.54M | 1.35% |
288,849
+2,860
|
|
||
21
Merus
MRUS
$7.28B
| $3.3M | 1.26% |
+62,719
|
|
||
22
Aquestive Therapeutics
AQST
$658M
| $3.14M | 1.2% |
947,489
+555,860
|
|
||
23
Ventyx Biosciences
VTYX
$660M
| $2.8M | 1.07% |
1,307,964
-1,274,691
|
|
||
|
MBX
24
MBX Biosciences
MBX
$1.11B
| $2.75M | 1.05% |
+241,000
|
|
||
25
IDEAYA Biosciences
IDYA
$2.82B
| $2.61M | 1% |
124,230
+1,230
|
|